The Malaysian Clinical Guidance on the Management of Postmenopausal Osteoporosis, 2012: A Summary
- 24 January 2013
- journal article
- review article
- Published by Wiley in International Journal of Rheumatic Diseases
- Vol. 16 (1) , 30-40
Abstract
Aim: This Clinical Guidance is aimed to help practitioners assess, diagnose and manage their patients with osteoporosis (OP), using the best available evidence.Methods: A literature search using PubMed (MEDLINE) and The Cochrane Library identified all relevant articles on OP and its assessment, diagnosis and treatment, from 2005, to update from the previous edition published in 2006. The studies were assessed and the level of evidence assigned; for each statement, studies with the highest level of evidence were used to frame the recommendation.Results: This article summarizes the diagnostic and treatment pathways for OP, highlighting the new data that have changed the way we assess and treat OP. Instead of starting treatment based on bone mineral density alone, there has been a move to assessing 10‐year fracture risk before treatment, using tools such as the Fracture Risk Assessment Tool (FRAX). There has been a re‐evaluation on calcium supplementation and more emphasis on the importance of vitamin D. There has been concern about the potential adverse effects of the long‐term usage of bisphosphonates, which we have discussed fully. New drugs that have been licensed since 2006 in Malaysia have been included.Conclusions: Adequate intake of calcium (1000 mg from both diet and supplements) and vitamin D (800 IU) daily remain important in the treatment of OP. However, in confirmed OP, pharmacological therapy with anti‐resorptives is the mainstay of treatment. Patients need to be regularly assessed while on medication and treatment adjusted as required.Keywords
This publication has 56 references indexed in Scilit:
- Non-pharmacological management of osteoporosis: a consensus of the Belgian Bone ClubOsteoporosis International, 2011
- The 2011 Report on Dietary Reference Intakes for Calcium and Vitamin D from the Institute of Medicine: What Clinicians Need to KnowThe Journal of Clinical Endocrinology & Metabolism, 2011
- Subtrochanteric fractures after long-term treatment with bisphosphonates: a European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, and International Osteoporosis Foundation Working Group ReportOsteoporosis International, 2010
- Denosumab for Prevention of Fractures in Postmenopausal Women with OsteoporosisNew England Journal of Medicine, 2009
- Dietary Calcium and Serum 25-Hydroxyvitamin D Status in Relation to BMD Among U.S. AdultsJournal of Bone and Mineral Research, 2009
- The Effects of Tibolone in Older Postmenopausal WomenNew England Journal of Medicine, 2008
- FRAX™ and the assessment of fracture probability in men and women from the UKOsteoporosis International, 2008
- Once-Yearly Zoledronic Acid for Treatment of Postmenopausal OsteoporosisNew England Journal of Medicine, 2007
- Effects of Oral Ibandronate Administered Daily or Intermittently on Fracture Risk in Postmenopausal OsteoporosisJournal of Bone and Mineral Research, 2004
- Hip fractures in the elderly: A world-wide projectionOsteoporosis International, 1992